An FDA recall covers ibuprofen oral suspension 20 mg/mL (150 mg per 7.5 mL) supplied in 12 mL berry-flavoured, alcohol-free oral syringes, from Safecor Health. The stated reason is cross-contamination with other products. The recall is ongoing and not yet classified, so its seriousness has not been graded.
This is a unit-dose hospital product rather than a retail bottle. It matters most to wards and fracture units that use pre-filled oral syringes for analgesia, particularly in children. There is no indication this affects Indian supply.
- Ask pharmacy whether your unit stocks the affected syringes.
- Quarantine any affected stock and use an alternative formulation.
- Report any unexpected reaction in a patient who received it.
Why it matters
Pre-filled analgesic syringes are used without a second look, which is exactly when contamination goes unnoticed.
Don't overread it
The recall is not yet classified; it does not by itself show that any patient was harmed.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for orthopaedics, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free